United States IUD Market Gaining Momentum—Projected to Grow at a CAGR of 4.9% by 2027
Published | 30 September 2021
United States IUD market is driven by the increasing number of unintended pregnancies in the United States. Additionally, supportive government initiatives across the country are likely to drive the market during the forecast period..
A study recently conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that United States IUD market was worth USD 900 Million in 2020. According to the study, the market is projected to grow at a CAGR of 4.9% during the forecast period (2021-2027) to reach the valuation of USD 1,210.1 Million by 2027. In recent years, there has been an increase in government initiatives aimed at improving access to family planning and reproductive health, which in turn is driving the United States IUD market. Approximately one-third of the maternal deaths in the United States can be prevented if women use effective contraception.
The United States government has been supporting family planning and reproductive health efforts for the past 50 years. It is the largest contributor to family planning and reproductive health globally. US government purchases and distributes contraceptives on a global scale, providing a major impetus for growth in the United States IUD market.
Increasing Regulatory Approvals are Becoming Lucrative Opportunity for Players
The government and regulatory bodies are increasingly funding public health initiatives. Several organizations, including the U.S. Food and Drug Administration and the World Health Organization, are involved in improving women's health in the United States. As a part of such initiatives, the FDA has approved several IUDs for use in the United States. FDA-approved IUD brands in the United States include Paragard, Mirena, Kyleena, Liletta, and Skyla. Out of these five brands, two brands are under the phase II and Phase III stages. Furthermore, some IUDs are in the development stage; therefore, players will have an opportunity to take advantage of this consolidated market.
The Hospital Segment is Driving the Growth of the United States IUD Market
The end-users are segmented into three categories, namely hospitals, gynecology centers, and community healthcare centers. Among these, the hospital's segment held the largest market share in 2020 and is estimated to maintain its dominance even during the forecast period. Since patients look for insurance coverage for IUD treatment, hospitals are the leading end-user. Additionally, the majority of the organizations have tie-ups with private and government hospitals, which support the hospital segmental growth.
Fig: Estimated Numbers Of Women (Million) Of Reproductive Age (15-49 Years) Using Various Contraceptive Methods, 1994 And 2019
Impact of COVID-19 on the United States IUD Market
The COVID-19 pandemic has had a substantial influence on the healthcare industry in the United States. Physical and economic barriers to contraception and other SRH (Sexual and Reproductive Health and Research) services have been created due to social distancing norms and the disruption caused by the pandemic. The majority of intrauterine devices sold are administered and prescribed by physicians. However, during the first few months of this pandemic in 2020, restrictions were placed on physician office visits without an emergency, causing a reduction in the demand for contraceptives. Additionally, the market demand is also expected to be hampered by telehealth services in certain areas of the United States. Also, many patients were unable to utilize their preferred methods of contraception due to the pandemic interruptions. In some cases, women have not been able to obtain long-acting birth control like IUDs or implants because they require in-person visits. They have instead opted for less effective methods such as birth control pills. Many patients who lost their jobs also lost their health insurance resulting in their inability to pay for their preferred method, whether an implant, IUD, or a prescription pill, patch or ring.
Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/united-states-iud-market/report-sample
Competitive Landscape
In the IUDs market, prominent market players compete based on price and product quality. Small and medium-sized market players are expected to show considerable improvements in the foreseeable future, given the moderate level of capital expenditure needed to set up a business. However, the large-sized companies are likely to aim for global expansion in a bid to gain a more considerable brand reputation. The leading players in the United States IUD market include Bayer AG, Cooper Companies (CooperSurgical Inc), and AbbVie. Bayer is the market leader in the area of Hormonal IUD.
- In November 2020, seven women’s health-focused organizations, including the American College of Obstetricians and Gynecologists, the Endometriosis Association, AbbVie, HealthyWomen, the International Pelvic Pain Society, GE Healthcare, and Black Women’s Health Imperative announced the formation of the Alliance for Endometriosis to improve the lives of the 1 in 10 women of reproductive age living with pelvic disorders in the United States.
- In February 2021, CooperSurgical announced the acquisition of California-based AEGEA Medical. The acquisition gives the right to CooperSurgical for AEGEA Mara Water vapor Ablation System, which is FDA-approved. This acquisition builds on over 30 years of women’s healthcare experience and complements CooperSurgical’s growing portfolio of medical products focused on clinic and practice-based women's health.
The report's in-depth analysis provides information about growth potential, upcoming trends, and the United States IUD market statistics. It also highlights the factors driving forecasts of total market size. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market. The report promises to provide recent technology trends in the United States IUD market, along with industry insights, to help decision-makers make sound strategic decisions.
About Us
BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662